Clinical isolates of primate immunodeficiency viruses, including human immunodeficiency virus type 1 (HIV-1), enter target cells by sequential binding to CD4 and the chemokine receptor CCR5, a member of the seven-transmembrane receptor family. HIV-1 variants which use additional chemokine receptors are present in the central nervous system or emerge during the course of infection. Simian immunodeficiency viruses (SIV) have been shown to use CCR5 as a coreceptor, but no other receptors for these viruses have been identified. Here we show that two orphan seven-transmembrane segment receptors, gprl and gpr15, serve as coreceptors for SIV, and are expressed in human alveolar macrophages. The more efficient of these, gpr15, is also expressed in human CD4 + T lymphocytes and activated rhesus macaque peripheral blood mononuclear cells. The gpr15 and gprl proteins lack several hallmarks ofchemokine receptors, but share with CCR5 an amino-terminal motif rich in tyrosine residues. These results underscore the potential diversity of seven-transmembrane segment receptors used as entry cofactors by primate immunodeficiency viruses, and may contribute to an understanding of viral variation and pathogenesis.
T
he human immunodeficiency viruses, HIV-1 and HIV-2, induce acquired immunodeficiency syndrome (AIDS) in humans, and simian immunodeficiency viruses (SIV) 1 can induce AIDS-like illness in Old World monkeys (1) (2) (3) (4) (5) . Isolates of HIV-1, the major cause of AIDS in humans, have been phylogenetically segregated into groups M and O (6) . HIV-2 and SIV form a distinct group of phylogenetically and antigenically related viruses (2, 3, (6) (7) (8) .
AIDS induced by HIV-1 or HIV-2 in humans or by SIV in monkeys is characterized by the depletion of CD4 + T lymphocytes, which represent a major target of viral infection in vivo (9) . Infection of other CD4 + cell types, such as tAbbreviations used in this paper: 7-TMS, seven-transmembrane segment; CAT, chloramphenicol acetyltransferase; SIV, simian immunodeficiency virus.
M. Farzan and H. Choe contributed equally to this work. monocytes in the blood, tissue macrophages, and microglial cells in the brain, has been suggested to be important for the pathogenesis of primate immunodeficiency viruses in the central nervous system and in the lungs (10) (11) (12) (13) (14) . Certain populations of dendritic cells in the blood and tissues may also be infected by these viruses (15, 16) .
The tropism of primate immunodeficiency viruses for CD4 + cells is explained by the use of the CD4 glycoprotein as a primary receptor for virus entry into the cell (17) (18) (19) . The viral envelope glycoproteins, which mediate virus entry, consist of the gpl20 exterior envelope glycoprotein and the gp41 transmembrane glycoprotein (20, 21) . The gp120 glycoprotein binds the CD4 molecule, following which the gp120-CD4 complex binds one of the members of the chemokine receptor subgroup of seven-transmembrahe segment (7-TMS) receptors (22) (23) (24) . This binding is believed to promote conformational changes in the gp120 and gp41 glycoproteins which result in the fusion of viral and cellular membranes (25) (26) (27) .
Viral variation, particularly that found in the gpl20 glycoprotein sequences (28, 29) , dictates the specific chemokine receptor which can be used as an entry cofactor. M-tropic HIV-1 variants which use the chemokine receptor CCR5 as a coreceptor predominate during the asymptomatic stages of infection (30) (31) (32) (33) (34) (35) . CCR5 is expressed on T lymphocytes, monocytes/macrophages, brain microglia, and dendritic cells (36) (37) (38) (39) . Individuals with defects in CCR5 expression are relatively resistant to HIV-1 infection (40) (41) (42) , indicating the critical contribution of this chemokine receptor to virus transmission. Some M-tropic brain isolates of HIV-1 also use the chemokine receptor CCR3 as a coreceptor, consistent with the expression of CCR3 in brain microglia (39) . Later in the course of infection, T-tropic HIV-1 variants emerge which can use chemokine receptors, especially CXCR4, but also CCR3 and CCR2b, in addition to CCR5 (34, 35, (43) (44) (45) . The emergence of these viruses has been suggested to coincide with a less favorable clinical prognosis (45) , perhaps through an expansion of the range ofinfectable CD4 ÷ T cell subsets (46) .
Primary isolates of HIV-2 and SIV have been shown to use rhesus macaque or human CCR5 as a coreceptor (47, 48) and are inhibited by the natural CCR5 ligands, MIP-loq MIP-113, and RANTES (49) . None of the other known HIV-1 coreceptors has been shown to be used by SIV, whereas some isolates of HIV-2 can use CXCR4 for entry into CD4-cells (50) . Several lines of evidence have suggested the existence of at least one other coreceptor for SIV. A human B cell/T cell hybrid, CEM×174, supports SIV entry, but lacks CCR5 and does not support efficient entry of HIV-1 viruses using CCR5 (48) . A neuroglioma cell line, U87, stably transfected with CD4, similarly supports entry of SIVmac239 but does not allow for efficient entry of any known HIV-1 virus (51). Finally, PBMCs from humans lacking a functional CCR5 receptor can nonetheless be infected with SIV (48). Here we identify two additional SIV coreceptors, gprl and gprl5, which are expressed in U87 and CEM× 174 cells, respectively. Both proteins are expressed in human alveolar macrophages, and the gpr15 protein is also expressed in CD4 + T lymphocytes.
Materials and Methods
Preparation of cDNA Libraries and eDNA. Messenger RNA was isolated using the CsC1 method and selection on magnetic beads with oligo-dT (Dynabeads; DYNAL, Inc., Lake Success, NY vested and assayed for CAT activity, which was determined by measuring the conversion of chloramphenicol to acetylated forms of chloramphenicol. The SIVmac239 and SIVm~c316 envelope glycoproteins were expressed from the previously described pS1VAgpv plasmid (47) . The HIV-1 envelope glycoproteins were expressed as previously described (27, 28) .
Analysis of Expression of 7-TMS Proteins in Cells and Tissues.
The expression of 7-TMS protein messenger RNA in CEM× 174 and U87 cells and primary human CD4 + T lymphocytes and alveolar macrophages was examined by synthesis of cDNA from polyadenylated RNA prepared from these cells, as described above. Primers corresponding to the nucleotide sequences encoding the first and third extracellular loops of the proteins were used for amplification by PCR. The identity of amplified fragments was confirmed by restriction enzyme digestion.
lope glycoproteins and expressed C A T were incubated with Cf2Th canine thymocytes transfected with plasmids expressing human CD4 and the 7 -T M S proteins. Table 1 lists the 7 -T M S proteins tested, summarizes their expression in C E M × 174, U87, and human CD4 + T cells, and indicates coreceptor activity for viruses with the SIVmac239 envelope glycoproteins. O f the 7 -T M S proteins tested, only gprl, gpr15, and C C R 5 supported the entry o f viruses with the Results W e had previously tested a number o f human chemokine receptors ( C C R 1 -C C R 5 , as well as C X C R 4 ) and found that of these only C C R 5 could support entry o f an HIV-1 virus pseudotyped with the envelope glycoproteins of a pathogenic, molecularly cloned SIV, SIVmac239 (47) . TO identify additional coreceptors which might be used by SIV, we screened c D N A libraries from SIV-infectable cells, C E M × 174 and U87, for the expression o f m R N A encoding k n o w n 7 -T M S proteins exhibiting some sequence similarity to chemokine receptors. The cDNAs which were shown to be expressed in either cell line were tested for the ability to support SIV and HIV-1 entry. Recombinant HIV-1 viruses which contained either HIV-1 or SIV enve- The percent conversion of chloramphenicol to acetylated forms is shown following incubation of comparable amounts of lysates derived from Cf2Th cells exposed to recombinant viruses. The CAT activity was calculated as described in the legend to Fig. 1 . In some cases, dilutions of the lysates were tested to bring the assay within the linear range and, thus, the reported values exceed 100%. Figure 2 . Expression ofgprl and gpr15 RNA in cells. The cDNA libraries from U87 and CEM×174 cells and from human alveolar macrophages, as well as cDNA prepared from human CD4 + T lymphocytes, were PCR amplified using gprl-or gpr15-specific primers.
SIVmac239 envelope glycoproteins. These three 7-TMS proteins also supported the entry of viruses with the macrophage-tropic SIVmac316 envelope glycoproteins (Fig. 1) . The SIV coreceptor activity exhibited by the gpr15 protein was greater than that of CCR5, whereas the coreceptor activity of gprl was ~30% that of C C R 5 ( Table 2 ). Most of the viruses with HIV-1 envelope glycoproteins (HXBc2, JP,.-FL, 89.6) did not infect Cf2Th cells expressing CD4 and gpr15, although the viruses with the M-tropic HIV-1 ADA and YU2 envelope glycoproteins demonstrated a low but reproducible signal in these cells ( Fig. 1 and Table 2 ). Following incubation with the ADA and YU2 viruses, the CAT conversion in the CD4 +, gpr15 + Cf2Th cells was <1% of that seen in the CD4 +, CC1<5 + control cells ( Table 2 ). Cf2Th cells expressing CD4 and gprl were not infected by viruses containing any of the HIV-1 envelope glycoproteins tested ( Table 2 ). The expression of gpr15 and gprl in different cell types was examined. Since specific reagents to detect these proteins were not available, expression was examined by R.NA analysis. A cDNA for gpr15 was readily detected in human CD4 + T lymphocytes, in human alveolar macrophages, in activated rhesus macaque PBMCs, and in CEMX 174 cells, but not in U87 cells (Table 1, Fig. 2 , and data not shown). By contrast, a cDNA for gprl could not be detected in primary human T lymphocytes, activated rhesus macaque PBMCs, or C E M × 174 cells, but was detected in U87 cells and human alveolar macrophages.
Discussion
HIV-1, HIV-2, and SIV all use CCR.5 as a coreceptor, indicating the importance of this protein in primate immunodeficiency virus pathogenesis (28, 30-33, 47, 48) . The use of other chemokine receptors by HIV-1 has been suggested to be important for infection of anatomical compartments such as the brain or for more efficient T cell depletion (39, 45, 46) . The identification o f g p r l and gpr15 as additional SIV coreceptors should assist efforts to understand the consequences of the use ofcoreceptors other than CCR5 in primate models of AIDS. While the in vivo contribution of gprl5 to SIV replication and pathogenesis requires further investigation, several lines of evidence indi- Figure 3 . An alignment of human gprl, human gprl5, rhesus CCR5 (rccrS), and human CCR.5 from the NH2-terminus through the first cysteine of CCR5 is shown. Tyrosines shown to be important for HIV-1 and SIVm~c239 entry are shown in bold. Other residues similarly positioned in these proteins are underlined. Sequences for gprl and gpr15 are provided in references 53 and 54, respectively. cate that gpr15 is an important SIV coreceptor. The gprl5 protein is expressed on CD4 + T lymphocytes, a major target cell for SIV infection in vivo (10) , and on alveolar macrophages. The gpr15 protein is also expressed on C E M × 174 cells, which are routinely used to passage SIV obtained from monkey PBMCs (52) . The rapid outgrowth of SIV viruses with minimal sequence changes on C E M × 174 cells suggests that these cells express a receptor used by primary SIV viruses. The weak use ofgprl5 by the ADA and YU2 HIV-1 viruses may be an inadvertent consequence of similarities in the amino-terminal regions of gprl5 and CCR5, or may indicate that adaptation to these receptors or to a related receptor occurs in some subsets ofHIV-1.
The in vivo contribution of gprl to primate immunodeficiency virus infection is also unresolved. The gprl protein weakly supported SIV infection in our studies. Whether this inefficient coreceptor activity is an intrinsic property of gprl or merely reflects low cell surface expression of gprl requires further investigation. While gprl is not apparently expressed on primary CD4 + lymphocytes, it is expressed on tissue macrophages and in the brain (53) and thus may play a role in SIV infection of particular nonlymphoid target cells.
In primary structure, gprl and gpr15 resemble the angiotensin II receptor and the orphan receptors dez and apj more than they do any of the known chemokine receptors (53, 54) . Gpr15, like dez and gprl, lacks the cysteines in the NH2-terminal region and the third extracellular loop which, in the chemokine receptors, are thought to be disulfide linked. It is interesting that despite the general sequence divergence of gprl5/gprl and other identified primate immunodeficiency virus coreceptors the gpr15 and gprl amino termini contain three tyrosines which align with similarly positioned tyrosines in CCR5 (Fig. 3) . Alteration of these tyrosines has been shown to decrease the efficiency with which C C R 5 supports the entry of SIV and M-tropic HIV-1 isolates (Farzan, M., H. Choe, andJ. Sodroski, unpublished observations). The identification of gpr15 and gprl as SIV coreceptors suggests a greater range and complexity of coreceptors for the primate immunodeficiency viruses than previously described. Comparative studies of these divergent coreceptors with the known coreceptors for these viruses should assist in the identification of common structural elements in 7-TMS proteins which serve as viral entry cofactors.
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